Compare M&T Bank Corporation (MTB) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
M&T Bank Corporation vs Neurocrine Biosciences Inc — how do they compare? M&T Bank Corporation trades at $248.99 (market cap $36.15B), while Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B). The key difference: M&T Bank Corporation is far larger — about 2.1× Neurocrine Biosciences Inc's market cap, and M&T Bank Corporation pays a 2.41% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| MTB | NBIX | |
|---|---|---|
Market Cap | $36.15B | $17.40B |
Sector | Financials | Health |
52-Week High | $254.04 | $180.55 |
52-Week Low | $178.63 | $123.10 |
Dividend Yield | 2.41% | — |
Enterprise Value | — | $16.49B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About M&T Bank Corporation
M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.
Read more on MTB →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
